In silico identification of novel and selective monoamine oxidase B inhibitors

Journal of Neural Transmission

Volumn 120, Issue 6, 2013, Pages 853-858

  Yelekçi, Kemal ^a   Büyüktürk, Bora ^a   Kayrak, Nurdan ^a  

^a KADIR HAS UNIVERSITY   (Turkey)

Author keywords

De novo design; Docking; In silico screening; Inhibition; Molecular modelling; Monoamine oxidase (MAO A, MAO B); Selective inhibitors

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MONOAMINE OXIDASE B INHIBITOR; OCTANOL; RASAGILINE; WATER;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; MOLECULAR LIBRARY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ANIMALS; COMPUTER SIMULATION; HUMANS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS;

EID: 84878719808     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0954-0     Document Type: Article

References (22)

1. Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848
2. Borstnar R, Repic M, Krzan M, Mavri J, Vianello R (2011) Irreversible inhibition of monoamine oxidase B by the antiparkinsonia medicines rasagiline and selegiline: a computational study. Eur J Org Chem 2011(32):6419-6433
3. Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Cardia MC, Distinto S (2007) Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives. J Med Chem 50:707-712
4. Edmondson DE, Binda C, Mattevi A (2007) Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys 464:269-276
5. Erdem SS, Karahan Ö, Yildiz I, Yelekci K (2006) A computational study on theamine-oxidation mechanism of monoamine oxidase: insight into the polar nucleophilic mechanism. Org Biomol Chem 4(4):646-658
6. Gökhan-Kelekçi N, Koyunoglu S, Yabanoglu S, Yelekçi K, Özgen Ö, Uçar G, Erol K, Kendi E, Yesilada A (2009) New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem 17:675-689
7. Harkcom WT, Bevan DR (2007) Molecular docking of inhibitors into monoamine oxidase B. Biochem Biophys Res Commun 360:401-406
8. Holtzheimer PE, Nemeroff CB (2006) Advances in the treatment of depression. NeuroTherapeutics 3:42-56
9. Hubálek F, Binda C, Li M, Herzig Y, Sterling J, Youdim MB, Mattevi A, Edmondson DE (2004) Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. J Med Chem 47(7):1760-1766
10. Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semi-empirical free energy force field with charge-based desolvation. J Comp Chem 28(6):1145-1152
11. Irwin JJ, Shoichet BK (2005) ZINC - a free database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177-182
12. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 19(14):1639-1662
13. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 16:2785-2791
14. Silverman RB, Hoffman SJ, Catus WBA III (1982) Mechanism for mitochondrial monoamine oxidase catalyzed amine oxidation. J Am Chem Soc 102:7126-7128
15. Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2 Å resolution: the control of opening the entry for substrates/inhibitors. PNAS 105(15):5739-5744
16. Toprakci M, Yelekci K (2005) Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (Ki) of a series of experimentally tested compounds. Bioorg Med Chem Lett 15:4438-4446
17. 2H kinetic isotope effects and pH dependence of catalysis as mechanistic probes of rat monoamine oxidase A: comparisons with the human enzyme. Biochemistry 50:7710-7717
18. Weinreb O, Amit T, Bar-Am O, Youdim MBH (2010) Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity. Prog Neurobiol 92:330-344
19. Weyler W, Hsu YP, Breakefield XO (1990) Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391-417
20. Yelekci K, Lu X, Silverman RB (1989) Electron-spin resonance studies of monoamin oxidase-B 1st direct evidence for a substrate radical intermediate. J Am Chem Soc 111:1138-1140
21. Yelekci K, Karahan Ö, Toprakci M (2007) Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties. J Neural Transm 114:725-732
22. Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295-309